Drug intelligence / Profile preview

eucalyptol

Development stage
Phase 1
Modality
Small Molecules
Administration
Oral, Topical, Inhalation, Intranasal
01

Overview

Eucalyptol is a naturally occurring monoterpenoid and cyclic ether that is the major component of eucalyptus oil. It is widely used as an ingredient in mouthwashes, cough suppressants, and cosmetics. Eucalyptol exerts its effects primarily through anti-inflammatory mechanisms by inhibiting proinflammatory cytokines such as Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), Tumor necrosis factor alpha (TNF-α), Interleukin 1 beta (IL-1β), and Interleukin 6 (IL-6) via the Extracellular signal-regulated kinase (ERK) pathway. It also acts as an antioxidant by reducing oxidative stress through radical scavenging and modulation of signaling pathways. Clinically, eucalyptol has been shown to control airway mucus hypersecretion in asthma and chronic obstructive pulmonary disease (COPD), reduce inflammation in nonpurulent rhinosinusitis, relieve pain when applied topically, and may have mucolytic and bronchodilating properties. Additionally, it has demonstrated cytotoxic activity against leukemia cells in vitro[1][6][7].

Brand names
Listerine Antiseptic
Other names
1,8-cineolecineolecajeputol
02

Targets

PPARG (Peroxisome proliferator-activated receptor gamma)

Beyond the preview

Go deeper on eucalyptol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on eucalyptol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call